Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia

New England Journal of Medicine

Volumn 363, Issue 23, 2010, Pages 2220-2227

  Musunuru, Kiran ^a,b,d,e   Pirruccello, James P ^a,d,e   Do, Ron ^a,d,f   Peloso, Gina M ^c,g   Guiducci, Candace ^d   Sougnez, Carrie ^d   Garimella, Kiran V ^d   Fisher, Sheila ^d   Abreu, Justin ^d   Barry, Andrew J ^d   Fennell, Tim ^d   Banks, Eric ^d   Ambrogio, Lauren ^d   Cibulskis, Kristian ^d   Kernytsky, Andrew ^d   Gonzalez, Elena ^d   Rudzicz, Nicholas ^f   Engert, James C ^f   DePristo, Mark A ^d   Daly, Mark J ^a,b,d   Cohen, Jonathan C ^h   Hobbs, Helen H ^h   Altshuler, David ^a,b,d   Schonfeld, Gustav ⁱ   Gabriel, Stacey B ^d   Yue, Pin ⁱ   Kathiresan, Sekar ^a,b,d   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MCGILL UNIVERSITY   (Canada)

^g FRAMINGHAM HEART STUDY   (United States)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

ⁱ WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE 3 PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; CHOLESTEROL BLOOD LEVEL; FAMILIAL COMBINED HYPOLIPIDEMIA; GENE MUTATION; GENE REPLICATION; GENE SEQUENCE; HETEROZYGOTE; HUMAN; HYPOLIPEMIA; LINKAGE ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 78649755576     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1002926     Document Type: Article

References (22)

1. Schonfeld G, Lin X, Yue P. Familial hypobetalipoproteinemia: genetics and metabolism. Cell Mol Life Sci 2005;62:1372-8.
2. Hooper AJ, van Bockxmeer FM, Burnett JR. Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism. Crit Rev Clin Lab Sci 2005;42:515-45.
3. Tarugi P, Lonardo A, Ballarini G, et al. Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B. Gastroenterology 1996;111:1125-33. (Pubitemid 26327617)
4. Schonfeld G, Patterson BW, Yablonskiy DA, et al. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis. J Lipid Res 2003;44:470-8.
5. Pulai JI, Neuman RJ, Groenewegen AW, Wu J, Schonfeld G. Genetic heterogeneity in familial hypobetalipoproteinemia: linkage and non-linkage to the apoB gene in Caucasian families. Am J Med Genet 1998;76:79-86. (Pubitemid 28104307)
6. Yuan B, Neuman R, Duan SH, et al. Linkage of a gene for familial hypobetalipoproteinemia to chromosome 3p21.1-22. Am J Hum Genet 2000;66:1699-704. (Pubitemid 30463090)
7. Sherva R, Yue P, Schonfeld G, Neuman RJ. Evidence for a quantitative trait locus affecting low levels of apolipoprotein B and low density lipoprotein on chromosome 10 in Caucasian families. J Lipid Res 2007;48:2632-9. (Pubitemid 350272848)
8. Yue P, Tanoli T, Wilhelm O, Patterson B, Yablonskiy D, Schonfeld G. Absence of fatty liver in familial hypobetalipoproteinemia linked to chromosome 3p21. Metabolism 2005;54:682-8.
9. Ng SB, Turner EH, Robertson PD, et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009;461:272-6.
10. Choi M, Scholl UI, Ji W, et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A 2009;106:19096-101.
11. Ng SB, Buckingham KJ, Lee C, et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 2010;42:30-5.
12. Elias N, Patterson BW, Schonfeld G. In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene. Arterioscler Thromb Vasc Biol 2000;20:1309-15.
13. Gnirke A, Melnikov A, Maguire J, et al. Solution hybrid selection with ultralong oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol 2009;27:182-9.
14. Romeo S, Yin W, Kozlitina J, et al. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J Clin Invest 2009;119:70-9.
15. Koishi R, Ando Y, Ono M, et al. Angptl3 regulates lipid metabolism in mice. Nat Genet 2002;30:151-7.
16. Köster A, Chao YB, Mosior M, et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 2005;146:4943-50. (Pubitemid 41446633)
17. Ando Y, Shimizugawa T, Takeshita S, et al. A decreased expression of angiopoietin- like 3 is protective against atherosclerosis in apoE-deficient mice. J Lipid Res 2003;44:1216-23. (Pubitemid 37279640)
18. Lee EC, Desai U, Gololobov G, et al. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL). J Biol Chem 2009;284:13735-45.
19. Shimizugawa T, Ono M, Shimamura M, et al. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem 2002;277:33742-8.
20. Shimamura M, Matsuda M, Yasumo H, et al. Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler Thromb Vasc Biol 2007;27:366-72.
21. Jin W, Wang X, Millar JS, et al. Hepatic proprotein convertases modulate HDL metabolism. Cell Metab 2007;6:129-36. (Pubitemid 47189092)
22. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010;466:707-13.